integra neurosciences holdings (uk) limited
integra neurosciences holdings (uk) limited Company Information
Company Number
03922160
Next Accounts
Sep 2025
Shareholders
caveangle limited
Group Structure
View All
Industry
Dormant Company
Registered Address
c/o corporation service company, 5 churchill place, 10th floor, london, E14 5HU
Website
www.integralife.comintegra neurosciences holdings (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of INTEGRA NEUROSCIENCES HOLDINGS (UK) LIMITED at £0 based on a Turnover of £0 and 0x industry multiple (adjusted for size and gross margin).
integra neurosciences holdings (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of INTEGRA NEUROSCIENCES HOLDINGS (UK) LIMITED at £0 based on an EBITDA of £0 and a 1.92x industry multiple (adjusted for size and gross margin).
integra neurosciences holdings (uk) limited Estimated Valuation
Pomanda estimates the enterprise value of INTEGRA NEUROSCIENCES HOLDINGS (UK) LIMITED at £0 based on Net Assets of £1 and 0.81x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Integra Neurosciences Holdings (uk) Limited Overview
Integra Neurosciences Holdings (uk) Limited is a live company located in london, E14 5HU with a Companies House number of 03922160. It operates in the dormant company sector, SIC Code 99999. Founded in February 2000, it's largest shareholder is caveangle limited with a 100% stake. Integra Neurosciences Holdings (uk) Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Integra Neurosciences Holdings (uk) Limited Health Check
There is insufficient data available to calculate a health check for Integra Neurosciences Holdings (Uk) Limited. Company Health Check FAQs
0 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (60)
- Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Integra Neurosciences Holdings (uk) Limited
- - Industry AVG
INTEGRA NEUROSCIENCES HOLDINGS (UK) LIMITED financials
Integra Neurosciences Holdings (Uk) Limited's latest turnover from December 2023 is 0 and the company has net assets of £1. According to their latest financial statements, we estimate that Integra Neurosciences Holdings (Uk) Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Admin Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Payable | 0 | 0 | 0 | 1,707,854 | 3,251,642 | 4,389,425 | 710,900 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 2,677,076 | 6,663,201 | 4,266,953 | 1,066,738 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 0 | 0 | 0 | -469,493,247 | 33,561,645 | 32,959,938 | 2,847,030 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | -469,493,247 | 33,561,645 | 32,959,938 | 2,847,030 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 1,115,479,224 | 8,526 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 0 | 0 | 0 | -1,584,972,471 | 33,553,119 | 32,959,938 | 2,847,030 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Number Of Employees | |||||||||||||||
| EBITDA* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 479,831,165 | 480,921,283 | 480,897,903 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 479,831,165 | 480,921,283 | 480,897,903 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 1 | 1 | 33,896,903 | 33,896,903 | 163,663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1 | 1 | 33,896,903 | 33,896,903 | 163,663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total assets | 1 | 1 | 33,896,903 | 33,896,903 | 479,994,828 | 480,921,283 | 480,897,903 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 8,183 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 3,146,773 | 3,217,647 | 3,200,111 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 0 | 3,154,956 | 3,217,647 | 3,200,111 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 34,288,642 | 68,705,525 | 93,545,256 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 34,288,642 | 68,705,525 | 93,545,256 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 37,443,598 | 71,923,172 | 96,745,367 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 1 | 1 | 33,896,903 | 33,896,903 | 442,551,230 | 408,998,111 | 384,152,536 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 |
| total shareholders funds | 1 | 1 | 33,896,903 | 33,896,903 | 442,551,230 | 408,998,111 | 384,152,536 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 | 6,870,850 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | -33,896,902 | 0 | 33,733,240 | 163,663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 0 | 33,896,902 | 0 | -33,733,240 | -163,663 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | -479,831,165 | -1,090,118 | 23,380 | 474,027,053 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,870,850 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | -8,183 | 8,183 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | -3,146,773 | -70,874 | 17,536 | 3,200,111 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | -34,288,642 | -34,416,883 | -24,839,731 | 93,545,256 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | 969,222 | 3,411,559 | -122,472 | 355,838 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | 0 | -33,896,902 | 0 | 1,139,843,768 | -31,068,015 | -33,059,030 | 471,535,861 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,870,850 |
| cash and cash equivalents | |||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
integra neurosciences holdings (uk) limited Credit Report and Business Information
Integra Neurosciences Holdings (uk) Limited Competitor Analysis
Perform a competitor analysis for integra neurosciences holdings (uk) limited by selecting its closest rivals, whether from the ACTIVITIES OF EXTRATERRITORIAL ORGANISATIONS AND BODIES sector, other mature companies, companies in E14 area or any other competitors across 12 key performance metrics.
integra neurosciences holdings (uk) limited Ownership
INTEGRA NEUROSCIENCES HOLDINGS (UK) LIMITED group structure
Integra Neurosciences Holdings (Uk) Limited has no subsidiary companies.
Ultimate parent company
INTEGRA LIFESCIENCES HOLDINGS CORP
#0064325
2 parents
INTEGRA NEUROSCIENCES HOLDINGS (UK) LIMITED
03922160
integra neurosciences holdings (uk) limited directors
Integra Neurosciences Holdings (Uk) Limited currently has 2 directors. The longest serving directors include Mr Jeffrey Mosebrook (Nov 2017) and Mr Timothy Swiss (Oct 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jeffrey Mosebrook | United States | 48 years | Nov 2017 | - | Director |
| Mr Timothy Swiss | United States | 44 years | Oct 2022 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1
0%
total assets
1
0%
cash
0
0%
net assets
Total assets minus all liabilities
integra neurosciences holdings (uk) limited company details
company number
03922160
Type
Private limited with Share Capital
industry
99999 - Dormant Company
incorporation date
February 2000
age
25
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
valueupper limited (March 2000)
accountant
-
auditor
BDO LLP
address
c/o corporation service company, 5 churchill place, 10th floor, london, E14 5HU
Bank
-
Legal Advisor
-
integra neurosciences holdings (uk) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to integra neurosciences holdings (uk) limited.
integra neurosciences holdings (uk) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INTEGRA NEUROSCIENCES HOLDINGS (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.
integra neurosciences holdings (uk) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
